Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01326260 · ClinicalTrials.gov registry record
Early Aggressive Correction of Severe Acidosis With Tris-hydroxymethylaminomethane (THAM)
A clinical trial, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- 60
- Enrollment target
NCT01326260: Clinical Trial study, sponsored by University of California, San Francisco.
NCT01326260 is a clinical trial that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01326260 was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This study involved the medical record review of resuscitation records for all severely-injured trauma patients requiring emergent surgical intervention and significant acidosis from 2005 through 2009.
Primary Outcome
Total amount of fluids and blood products used during the operative and 72 hr post-operative period.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2010-07 |
| Est. Completion | 2015-05 |
Why NCT01326260 stopped before completion
NCT01326260 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01326260 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01326260 about?
NCT01326260 is a clinical study titled "Early Aggressive Correction of Severe Acidosis With Tris-hydroxymethylaminomethane (THAM)". This study involved the medical record review of resuscitation records for all severely-injured trauma patients requiring emergent surgical intervention and significant acidosis from 2005 through 2009.
What is the current status of trial NCT01326260?
This trial is currently terminated. The enrollment target is 60 participants. The study started on 2010-07. Estimated completion is 2015-05.
Who is sponsoring clinical trial NCT01326260?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia